v3.25.2
Accrued Expenses and Other Current Liabilities
6 Months Ended
Jun. 30, 2025
Accrued Expenses and Other Current Liabilities [Abstract]  
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

8. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES 

 

Accrued expenses and other current liabilities consisted of the following as of the periods indicated:

 

   June 30,   December 31, 
   2025   2024 
Accrued research and development expense  $1,799,583   $1,799,583 
Accrued directors and officers (owners) compensation   996,675    1,025,867 
Cash portion of the Lind Note repayments   769,660    127,759 
Accrued compensation and employee benefits   160,914    126,106 
Others   564,132    557,866 
Total  $4,290,964   $3,509,422